New #CochraneReview assesses the benefits and harms of #risedronate in the primary and secondary prevention of #osteoporotic #fractures for #postmenopausal women at lower and higher risk for fractures, respectively. https://t.co/JHzNkHN6GR https://t.co/O4p
3,485 followers
1,027 followers
Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women - PubMed https://t.co/l3UVdjjetc
13,719 followers
Lee la revisión completa aquí https://t.co/JJqadinRcj (6/6) #menopausia #osteoporosis
25 followers
RT @FF_Network: New Cochrane Review presents what we know from the evidence up to 24 March 2021 about the effect of risedronate for prevent…